AQR Capital Management, LLC and AQR Capital Management Holdings, LLC filed a Schedule 13G with the SEC on November 13, 2026, disclosing a combined beneficial ownership position in Insulet Corp common stock as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: 4,748,776 shares of Insulet Corp Common Stock, $0.001 par value per share, representing 6.85% of the class.
  • Shared voting power: Both AQR Capital Management, LLC and AQR Capital Management Holdings, LLC each report shared voting power over 4,642,483 shares.
  • Shared dispositive power: Both entities each report shared dispositive power over 4,748,776 shares, with sole voting and sole dispositive power reported as zero for each.
  • Event date: The filing is triggered by an event dated September 30, 2026.
  • Relationship between filers: According to the filing, AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC.
  • Certification: The filing certifies that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

AQR Discloses 4,748,776-Share Position in Insulet Corp

AQR Capital Management, LLC, classified as an investment adviser (type "IA"), and its parent AQR Capital Management Holdings, LLC, classified as a holding company (type "HC"), jointly filed a Schedule 13G regarding their holdings in Insulet Corp, the medical device issuer headquartered at 100 Nagog Park, Acton, Massachusetts 01720. The filing was submitted on November 13, 2026, based on a triggering event date of September 30, 2026. Both entities are organized in the United States and maintain their principal offices at One Greenwich Plaza, Suite 130, Greenwich, Connecticut 06830.

According to the filing, both AQR Capital Management, LLC and AQR Capital Management Holdings, LLC each report aggregate beneficial ownership of 4,748,776 shares, representing 6.85% of the outstanding class. Each entity reports zero sole voting power and zero sole dispositive power. Shared voting power is listed as 4,642,483 shares for each entity, while shared dispositive power covers the full 4,748,776 shares for each. The filing does not identify the specific accounts or funds underlying these positions beyond directing readers to Item 2(a).

The two filers agreed, as stated in the exhibit information, that the Schedule 13G is filed jointly on behalf of each party. Henry Parkin signed the document as Authorized Signatory for both AQR Capital Management, LLC and AQR Capital Management Holdings, LLC on November 13, 2026. No group membership, dissolution of a group, or ownership of 5% or less is noted as applicable in this filing.

What Was Disclosed

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC disclosed a combined 4,748,776-share beneficial ownership stake in Insulet Corp, equal to 6.85% of the class, via a Schedule 13G filed November 13, 2026 and reflecting positions as of September 30, 2026.